Header Logo

Connection

JACOB MANDEL to Tumor Microenvironment

Back to Details
This is a "connection" page, showing publications JACOB MANDEL has written about Tumor Microenvironment.
JACOB MANDEL
Connection Strength
0.033
Tumor Microenvironment
  1. Window-of-opportunity clinical trial of pembrolizumab in patients with recurrent glioblastoma reveals predominance of immune-suppressive macrophages. Neuro Oncol. 2020 04 15; 22(4):539-549.
    View in: PubMed
    Score: 0.033
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.